Mako SmartRobotics
Stryker · #2 in Medical
Robotic-arm assisted orthopedic surgery: total knee, total hip, partial knee, spine and shoulder procedures
HYDROS is PROCEPT BioRobotics' AI-enabled surgical robot for Aquablation therapy, which removes prostate tissue in men with benign prostatic hyperplasia using a heat-free, ultrasound-guided waterjet. FDA-cleared in August 2024 as the successor to AquaBeam (cleared 2017), it is commercially available in the US, launched internationally in March 2026, and drove more than 13,100 US procedures in Q2 2026 alone.
- HYDROS design draws on insights from over 50,000 Aquablation procedures performed on the predecessor AquaBeam system [source]
- Q2 2026 revenue of $94.5 million, up 19% year over year, driven by a growing HYDROS install base [source]
- European Association of Urology guidance strongly recommending Aquablation over TURP for moderate-to-severe BPH bolstered adoption [source]
Specifications
| Specification | Value | Confidence | Source |
|---|---|---|---|
| Treatment modality | Robotically controlled, heat-free waterjet resection of prostate tissue (Aquablation therapy) | verified | ir.procept-biorobotics.com (2026-09-01) |
| AI system | FirstAssist AI treatment planning, helping urologists interpret real-time ultrasound | verified | ir.procept-biorobotics.com (2026-09-01) |
| Imaging | Real-time ultrasound image guidance with fully integrated advanced ultrasound system | verified | ir.procept-biorobotics.com (2026-09-01) |
| Cystoscope | Pre-assembled single-use digital cystoscope; no scope reprocessing | verified | ir.procept-biorobotics.com (2026-09-01) |
| US procedures, Q2 2026 | 13,100+ (up ~21% year over year) procedures | verified | ir.procept-biorobotics.com (2026-09-01) |
| US systems delivered, Q2 2026 | 65 (including 14 replacement systems) systems | verified | ir.procept-biorobotics.com (2026-09-01) |
Every spec is cited to its source with a retrieval date. verified = manufacturer-published · reported = reputable press/analyst. Verify with the manufacturer before purchase decisions.
Change timeline
- milestone Q2 2026 results: $94.5M revenue, 65 US systems delivered, 13,100+ US procedures [source]
- launch International launch of the HYDROS Robotic System announced [source]
- milestone FDA grants 510(k) clearance for HYDROS; immediate US availability [source]
Our take
Unlike the general-purpose soft-tissue platforms, HYDROS is a single-procedure specialist, and that focus is its strength: a defined reimbursement pathway, strengthening European guideline support and a razor-and-blade model built on ~$3,550 single-use handpieces. At a reported ~$495K system price it is far cheaper than multiport robots, making it accessible to urology programs and ASCs. The obvious caveat is concentration risk: its fortunes ride on one indication, BPH.
Best suited for
- Surgical treatment of benign prostatic hyperplasia (BPH)
- Hospital and ambulatory urology programs offering Aquablation therapy
Compare
- procept hydros vs stryker mako smartrobotics
- procept hydros vs intuitive da vinci 5
- Compare HYDROS Robotic System against any robot →
HYDROS Robotic System: common questions
How much does the HYDROS robot cost?
PROCEPT reported a US average selling price of about $495,000 for new HYDROS systems in Q2 2026, plus roughly $3,550 per single-use handpiece per procedure.
What does the HYDROS system treat?
It delivers Aquablation therapy, a heat-free robotic waterjet resection of prostate tissue, for benign prostatic hyperplasia (enlarged prostate). It is not a cancer treatment platform.
Is HYDROS FDA cleared?
Yes. The FDA granted 510(k) clearance on August 21, 2024, and the system was immediately available in the United States. Its predecessor AquaBeam was cleared in 2017.
HYDROS vs AquaBeam: what changed?
HYDROS adds FirstAssist AI treatment planning, integrated advanced ultrasound, a single-use digital cystoscope and a streamlined workflow, building on insights from over 50,000 AquaBeam procedures.
How widely is Aquablation used?
US procedures exceeded 13,100 in Q2 2026 (up about 21% year over year), and PROCEPT began international HYDROS launches in March 2026.
Sources
- PROCEPT BioRobotics — ir.procept-biorobotics.com, retrieved 2026-09-01
- PROCEPT BioRobotics — ir.procept-biorobotics.com, retrieved 2026-09-01
- MassDevice — massdevice.com, retrieved 2026-09-01
- Urology Times — urologytimes.com, retrieved 2026-09-01
- Simply Wall St — simplywall.st, retrieved 2026-09-01
Related medical robots
da Vinci 5
Intuitive Surgical · #3 in Medical
Robotic-assisted minimally invasive soft-tissue surgery across urology, gynecology, general surgery, thoracic and, since 2026, selected cardiac procedures
Hugo RAS
Medtronic · #4 in Medical
Robotic-assisted minimally invasive soft-tissue surgery; US indication currently covers urologic procedures such as prostatectomy, nephrectomy and cystectomy
Moxi
Diligent Robotics · #5 in Medical
Autonomous hospital logistics: point-to-point delivery of medications, lab samples and supplies so nurses and clinical staff spend less time fetching